Zhi-Cheng Yang, Lei Zhang, Ying-Bin Xi, Gui-Hua Jiang, He Lin, Hui Pan, Zhi-Hao Wang
{"title":"Association between albumin changes and prognosis in older patients with acute myocardial infarction.","authors":"Zhi-Cheng Yang, Lei Zhang, Ying-Bin Xi, Gui-Hua Jiang, He Lin, Hui Pan, Zhi-Hao Wang","doi":"10.3389/fmed.2024.1508868","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Acute myocardial infarction (AMI) is the leading cause of death in the world. Therefore, early identification of the prognosis of older patients with AMI are particularly urgent, and better to improve treatment. This study aimed to explore the association between albumin changes and prognosis in older patients with AMI.</p><p><strong>Methods: </strong>Outcomes included all-cause death during hospitalization, cardiac death, gastrointestinal hemorrhage, nonfatal myocardial infarction, acute heart failure, and severe arrhythmia. Multivariable-adjusted Cox regression analysis and curve fitting were used to assess the relationship between albumin changes and prognosis in patients with AMI.</p><p><strong>Results: </strong>Our study included 288 older patients with AMI. A S-shaped association between the albumin changes and mortality of patients with AMI was found. For all-cause death, we found two inflection points were - 3.27 and 0.92 g/L. On the left side of -3.27 g/L, the OR was 0.41 (OR: 0.41, 95%CI: 0.32-0.64, <i>p</i> < 0.05). On the right side of 0.92 g/L, the OR was 0.58 (OR: 0.58, 95%CI: 0.34-0.86, <i>p</i> < 0.05). The OR was 2.12 between -3.27 and 0.92 g/L (OR: 2.12, 95%CI: 1.16-6.24, <i>p</i> < 0.05). For cardiac death, two inflection points were - 3.19 and 1.17 g/L. On the left side of -3.19 g/L, the OR was 0.45 (OR: 0.45, 95%CI: 0.28-0.79, <i>p</i> < 0.05). On the right side of 1.17 g/L, the OR was 0.63 (OR: 0.63, 95%CI: 0.38-0.86, <i>p</i> < 0.05). The OR was 4.53 between -3.19 and 1.17 g/L (OR: 4.53, 95%CI: 0.90-12.52, <i>p</i> > 0.05). After adjusting for all potential covariates, albumin changes were negatively associated with gastrointestinal hemorrhage (OR: 0.87; 95%CI: 0.81-0.94, <i>p</i> < 0.001). After adjusting for all potential covariates, albumin changes were negatively associated with acute heart failure (OR: 0.86; 95%CI: 0.75-0.99, <i>p</i> = 0.046).</p><p><strong>Conclusion: </strong>Out findings showed that a S-shaped association between the albumin changes and mortality of older AMI patients, with the inflection of roughly -3.27 g/L and 0.92/L. And changes in albumin levels are negatively correlated with gastrointestinal bleeding and acute heart failure. These findings were helpful for the clinical treatment.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"11 ","pages":"1508868"},"PeriodicalIF":3.1000,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11788366/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2024.1508868","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background and aims: Acute myocardial infarction (AMI) is the leading cause of death in the world. Therefore, early identification of the prognosis of older patients with AMI are particularly urgent, and better to improve treatment. This study aimed to explore the association between albumin changes and prognosis in older patients with AMI.
Methods: Outcomes included all-cause death during hospitalization, cardiac death, gastrointestinal hemorrhage, nonfatal myocardial infarction, acute heart failure, and severe arrhythmia. Multivariable-adjusted Cox regression analysis and curve fitting were used to assess the relationship between albumin changes and prognosis in patients with AMI.
Results: Our study included 288 older patients with AMI. A S-shaped association between the albumin changes and mortality of patients with AMI was found. For all-cause death, we found two inflection points were - 3.27 and 0.92 g/L. On the left side of -3.27 g/L, the OR was 0.41 (OR: 0.41, 95%CI: 0.32-0.64, p < 0.05). On the right side of 0.92 g/L, the OR was 0.58 (OR: 0.58, 95%CI: 0.34-0.86, p < 0.05). The OR was 2.12 between -3.27 and 0.92 g/L (OR: 2.12, 95%CI: 1.16-6.24, p < 0.05). For cardiac death, two inflection points were - 3.19 and 1.17 g/L. On the left side of -3.19 g/L, the OR was 0.45 (OR: 0.45, 95%CI: 0.28-0.79, p < 0.05). On the right side of 1.17 g/L, the OR was 0.63 (OR: 0.63, 95%CI: 0.38-0.86, p < 0.05). The OR was 4.53 between -3.19 and 1.17 g/L (OR: 4.53, 95%CI: 0.90-12.52, p > 0.05). After adjusting for all potential covariates, albumin changes were negatively associated with gastrointestinal hemorrhage (OR: 0.87; 95%CI: 0.81-0.94, p < 0.001). After adjusting for all potential covariates, albumin changes were negatively associated with acute heart failure (OR: 0.86; 95%CI: 0.75-0.99, p = 0.046).
Conclusion: Out findings showed that a S-shaped association between the albumin changes and mortality of older AMI patients, with the inflection of roughly -3.27 g/L and 0.92/L. And changes in albumin levels are negatively correlated with gastrointestinal bleeding and acute heart failure. These findings were helpful for the clinical treatment.
背景和目的:急性心肌梗死(AMI)是世界上主要的死亡原因。因此,早期识别老年AMI患者的预后就显得尤为迫切,并能更好地改善治疗。本研究旨在探讨老年AMI患者白蛋白变化与预后的关系。方法:结果包括住院期间全因死亡、心源性死亡、胃肠道出血、非致死性心肌梗死、急性心力衰竭和严重心律失常。采用多变量校正Cox回归分析和曲线拟合评估AMI患者白蛋白变化与预后的关系。结果:我们的研究纳入了288例老年AMI患者。发现白蛋白变化与AMI患者死亡率呈s型相关。对于全因死亡,我们发现两个拐点为 - 3.27和0.92 g/L。在-3.27 g/L左侧,OR为0.41 (OR: 0.41, 95%CI: 0.32-0.64, p p p p p p > 0.05)。在对所有可能的协变量进行校正后,白蛋白变化与胃肠道出血呈负相关(OR: 0.87;95%CI: 0.81-0.94, p p = 0.046)。结论:我们的研究结果显示老年AMI患者白蛋白变化与死亡率呈s型相关,其变化幅度约为-3.27 g/L和0.92/L。白蛋白水平的变化与胃肠道出血和急性心力衰竭呈负相关。这些发现对临床治疗有一定的帮助。
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world